Wetzel Investment Advisors’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$297K Sell
1,343
-169
-11% -$46.8K 0.1% 107
2026
Q1
$447K Sell
1,512
-568
-27% -$169K 0.18% 78
2025
Q4
$568K Sell
2,080
-14
-0.7% -$3.8K 0.23% 62
2025
Q3
$566K Sell
2,094
-15
-0.7% -$4.08K 0.24% 62
2025
Q2
$581K Sell
2,109
-144
-6% -$39.2K 0.27% 61
2025
Q1
$598K Sell
2,253
-14
-0.6% -$3.45K 0.3% 59
2024
Q4
$553K Sell
2,267
-75
-3% -$17.2K 0.27% 65
2024
Q3
$517K Buy
2,342
+638
+37% +$132K 0.26% 67
2024
Q2
$367K Sell
1,704
-716
-30% -$148K 0.21% 79
2024
Q1
$507K Buy
2,420
+36
+2% +$7.56K 0.3% 60
2023
Q4
$502K Buy
+2,384
New +$509K 0.31% 54

Other funds holding CME

Wetzel Investment Advisors's CME Position: Q2 2026 in Review

Wetzel Investment Advisors reduced its CME Group (CME) stake by 11% in Q2 2026, selling an estimated $46.8K and leaving 1,343 shares worth $297K. The position accounts for 0.1% of the portfolio, ranked #107.

Wetzel Investment Advisors first reported a position in CME in Q4 2023 and has held it in 11 quarters since. The position peaked at $598K in Q1 2025. 441 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Wetzel Investment Advisors held 1,343 shares of CME Group worth $297K as of Q2 2026.
  • Wetzel Investment Advisors sold 169 CME Group shares in Q2 2026, an estimated $46.8K.
  • CME Group made up 0.1% of Wetzel Investment Advisors's portfolio in Q2 2026, its #107 holding.
  • Wetzel Investment Advisors first reported a position in CME Group in Q4 2023 and has held it in 11 quarters since.
  • Wetzel Investment Advisors's CME Group position peaked at $598K in Q1 2025.
  • 441 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Wetzel Investment Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.